Draamakasvatus tunne- ja vuorovaikutustaitojen tukena 0–6-vuotiailla

Tiivistelmä. Tutkielmamme tavoitteena on koota yhteen, miten draamakasvatuksella voidaan tukea ja kehittää lasten tunne- ja vuorovaikutustaitoja. Tutkielmamme on kuvaileva kirjallisuuskatsaus, jossa syvennymme draamakasvatukseen tunne- ja vuorovaikutustaitojen tukena. Pyrimme myös tutkielmallamme tuomaan lisää ymmärrystä varhaiskasvatuksen henkilöstölle draamakasvatuksen tuomasta tuesta lasten tunne- ja vuorovaikutustaitoihin. Aiheemme on ajankohtainen ja etenkin tunnetaitojen harjoittaminen on isossa roolissa varhaiskasvatuksessa ja esiopetuksessa. Teoreettisen viitekehyksemme keskeisimmät käsitteet ovat draamakasvatus, tunne- ja vuorovaikutustaidot ja varhaiskasvatus. Vastaamme kirjallisuuden ja eri aineistojen avulla tutkimuskysymykseemme, “Miten draamakasvatuksella voidaan tukea 0–6-vuotiaiden lasten tunne- ja vuorovaikutustaitoja?”. Yhdistämme ja arvioimme tutkimuksessamme jo olemassa olevaa tietoa draamakasvatuksen vaikutuksesta lasten tunne- ja vuorovaikutustaitoihin ja millä draamakasvatuksen keinoilla niitä voidaan tukea. Lopuksi pohdimme ja arvioimme aineistojen perusteella saatuja tutkimustuloksiamme. Aineistona pyrimme käyttämään mahdollisimman tuoreita lähteitä, mutta tutkimuksia aiheesta on vielä vähän, joten olemme myös hyödyntäneet kirjallisuutta ja muuta aineistoa aikaisemmilta vuosilta. Aineistomme koostuu suomalaisista kirjoista ja artikkeleista sekä muusta aineistosta. Olemme myös käyttäneet lähteinä ulkomaisia artikkeleita. Aineiston perusteella draamakasvatuksella voidaan tukea lapsen tunne- ja vuorovaikutustaitoja, ja varhaiskasvatuksen henkilöstön tulisi tuntea draamakasvatuksen työtapoja, joita he voisivat toteuttaa tietoisesti ja suunnitelmallisesti. Kirjallisuudessa ja artikkeleissa tulee ilmi, että opettajan tulee olla tietoinen erilaisista draamakasvatuksen toimintatavoista ja käsitteistä. Jokainen varhaiskasvatuksessa työskentelevä voi omassa työssään rohkeasti soveltaa ja kehittää draaman genrejä omalle ryhmälle sopivaksi

Genetic architecture of human plasma lipidome and its link to cardiovascular disease

Abstract Understanding genetic architecture of plasma lipidome could provide better insights into lipid metabolism and its link to cardiovascular diseases (CVDs). Here, we perform genome-wide association analyses of 141 lipid species (n = 2,181 individuals), followed by phenome-wide scans with 25 CVD related phenotypes (n = 511,700 individuals). We identify 35 lipid-species-associated loci (P <5 ×10−8), 10 of which associate with CVD risk including five new loci-COL5A1, GLTPD2, SPTLC3, MBOAT7 and GALNT16 (false discovery rate<0.05). We identify loci for lipid species that are shown to predict CVD e.g., SPTLC3 for CER(d18:1/24:1). We show that lipoprotein lipase (LPL) may more efficiently hydrolyze medium length triacylglycerides (TAGs) than others. Polyunsaturated lipids have highest heritability and genetic correlations, suggesting considerable genetic regulation at fatty acids levels. We find low genetic correlations between traditional lipids and lipid species. Our results show that lipidomic profiles capture information beyond traditional lipids and identify genetic variants modifying lipid levels and risk of CVD

Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices

Abstract Autosomal genetic analyses of blood lipids have yielded key insights for coronary heart disease (CHD). However, X chromosome genetic variation is understudied for blood lipids in large sample sizes. We now analyze genetic and blood lipid data in a high-coverage whole X chromosome sequencing study of 65,322 multi-ancestry participants and perform replication among 456,893 European participants. Common alleles on chromosome Xq23 are strongly associated with reduced total cholesterol, LDL cholesterol, and triglycerides (min P = 8.5 × 10−72), with similar effects for males and females. Chromosome Xq23 lipid-lowering alleles are associated with reduced odds for CHD among 42,545 cases and 591,247 controls (P = 1.7 × 10−4), and reduced odds for diabetes mellitus type 2 among 54,095 cases and 573,885 controls (P = 1.4 × 10−5). Although we observe an association with increased BMI, waist-to-hip ratio adjusted for BMI is reduced, bioimpedance analyses indicate increased gluteofemoral fat, and abdominal MRI analyses indicate reduced visceral adiposity. Co-localization analyses strongly correlate increased CHRDL1 gene expression, particularly in adipose tissue, with reduced concentrations of blood lipids

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Characterization of the genetic landscape of Alzheimer’s disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/‘proxy’ AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele

Evidence of a causal effect of genetic tendency to gain muscle mass on uterine leiomyomata

Uterine leiomyomata (UL) are the most common tumours of the female genital tract and the primary cause of surgical removal of the uterus. Genetic factors contribute to UL susceptibility. To add understanding to the heritable genetic risk factors, we conduct a genome-wide association study (GWAS) of UL in up to 426,558 European women from FinnGen and a previous UL meta-GWAS. In addition to the 50 known UL loci, we identify 22 loci that have not been associated with UL in prior studies. UL-associated loci harbour genes enriched for development, growth, and cellular senescence. Of particular interest are the smooth muscle cell differentiation and proliferation-regulating genes functioning on the myocardin-cyclin dependent kinase inhibitor 1A pathway. Our results further suggest that genetic predisposition to increased fat-free mass may be causally related to higher UL risk, underscoring the involvement of altered muscle tissue biology in UL pathophysiology. Overall, our findings add to the understanding of the genetic pathways underlying UL, which may aid in developing novel therapeutics.Peer reviewe

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Characterization of the genetic landscape of Alzheimer’s disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/‘proxy’ AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele